PortfoliosLab logo

Anebulo Pharmaceuticals, Inc. (ANEB)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS0345691036
CUSIP034569103
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.91
Year Range$2.70 - $7.70
EMA (50)$3.73
EMA (200)$5.11
Average Volume$19.91K
Market Capitalization$91.28M

ANEBShare Price Chart


Chart placeholderClick Calculate to get results

ANEBPerformance

The chart shows the growth of $10,000 invested in Anebulo Pharmaceuticals, Inc. in May 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,586 for a total return of roughly -44.14%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%MarchAprilMayJuneJulyAugust
-44.30%
-7.55%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-26.09%8.19%
6M-48.35%-7.42%
YTD-36.42%-13.03%
1Y-43.19%-5.85%
5Y-37.24%-1.08%
10Y-37.24%-1.08%

ANEBMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20227.48%10.29%-2.88%-47.60%-27.22%92.59%-42.60%30.99%
202117.14%-16.83%6.42%-7.00%-2.96%1.53%-9.77%2.50%

ANEBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anebulo Pharmaceuticals, Inc. Sharpe ratio is -0.52. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00May 08May 15May 22May 29Jun 05Jun 12Jun 19Jun 26Jul 03Jul 10Jul 17Jul 24Jul 31
-0.52
-0.31
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBDividend History


Anebulo Pharmaceuticals, Inc. doesn't pay dividends

ANEBDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-56.31%
-13.58%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ANEBWorst Drawdowns

The table below shows the maximum drawdowns of the Anebulo Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anebulo Pharmaceuticals, Inc. is 69.83%, recorded on May 31, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-69.83%May 24, 2021258May 31, 2022
-1.41%May 10, 20217May 18, 20211May 19, 20218

ANEBVolatility Chart

Current Anebulo Pharmaceuticals, Inc. volatility is 121.30%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MarchAprilMayJuneJulyAugust
121.30%
19.67%
ANEB (Anebulo Pharmaceuticals, Inc.)
Benchmark (^GSPC)